ArticleFrontiers in public health2026
Global burden of disease 2021: particulate matter pollution-attributable burden of upper respiratory infections, otitis media, and lower respiratory infections.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global burden of lower respiratory infections (LRIs), upper respiratory infections (URIs), and otitis media attributable to air pollution has exhibited notable temporal patterns. Our study analyzed the patterns in disability-adjusted life years (DALYs) and age-standardized DALY rates (ASDRs) attributable to particulate matter pollution (PMP) for LRIs, and for URIs and otitis media (infants <1 year), using Global Burden of Disease (GBD) 1990-2021 estimates. We applied frontier analysis to estimate improvement potential by development status, assessed cross-country inequality, and used decomposition analysis to evaluate the contributions of population growth, aging, and epidemiological changes. Furthermore, an autoregressive integrated moving average (ARIMA) model was employed to forecast trends through 2031. Our findings revealed that the PMP -attributable burden of LRIs, infant URIs and infant otitis media, decreased globally from 1990 to 2021, with notable reductions in East Asia (LRIs, URIs), and Central Europe (otitis media). Despite progress, burdens remains highest in low-socio-demographic index (SDI) regions, indicating substantial potential for further reduction. Decomposition attributed most global declines to epidemiological change, whereas population growth increased burden in low-SDI regions. Projections suggest continued declines for PMP -attributable burden of LRIs and infant URIs but a slight rise for infant otitis media by 2031. These findings highlight the need for further targeted preventive interventions, especially in high-burden regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.